Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 1
2005 5
2006 8
2007 8
2008 2
2009 9
2010 9
2011 13
2012 15
2013 19
2014 14
2015 16
2016 28
2017 28
2018 42
2019 44
2020 64
2021 89
2022 114
2023 125
2024 126
2025 124

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

819 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.
Modi S, Jacot W, Yamashita T, Sohn J, Vidal M, Tokunaga E, Tsurutani J, Ueno NT, Prat A, Chae YS, Lee KS, Niikura N, Park YH, Xu B, Wang X, Gil-Gil M, Li W, Pierga JY, Im SA, Moore HCF, Rugo HS, Yerushalmi R, Zagouri F, Gombos A, Kim SB, Liu Q, Luo T, Saura C, Schmid P, Sun T, Gambhire D, Yung L, Wang Y, Singh J, Vitazka P, Meinhardt G, Harbeck N, Cameron DA; DESTINY-Breast04 Trial Investigators. Modi S, et al. Among authors: luo t. N Engl J Med. 2022 Jul 7;387(1):9-20. doi: 10.1056/NEJMoa2203690. Epub 2022 Jun 5. N Engl J Med. 2022. PMID: 35665782 Free PMC article. Clinical Trial.
HER2-targeted therapies in cancer: a systematic review.
Zhu K, Yang X, Tai H, Zhong X, Luo T, Zheng H. Zhu K, et al. Among authors: luo t. Biomark Res. 2024 Feb 2;12(1):16. doi: 10.1186/s40364-024-00565-1. Biomark Res. 2024. PMID: 38308374 Free PMC article. Review.
Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial.
Ma F, Yan M, Li W, Ouyang Q, Tong Z, Teng Y, Wang Y, Wang S, Geng C, Luo T, Zhong J, Zhang Q, Liu Q, Zeng X, Sun T, Mo Q, Liu H, Cheng Y, Cheng J, Wang X, Nie J, Yang J, Wu X, Wang X, Li H, Ye C, Dong F, Wu S, Zhu X, Xu B; PHILA Investigators. Ma F, et al. Among authors: luo t. BMJ. 2023 Oct 31;383:e076065. doi: 10.1136/bmj-2023-076065. BMJ. 2023. PMID: 37907210 Free PMC article. Clinical Trial.
Molecular pathways and diagnosis in spatially resolved Alzheimer's hippocampal atlas.
Wang P, Han L, Wang L, Tao Q, Guo Z, Luo T, He Y, Xu Z, Yu J, Liu Y, Wu Z, Xu B, Jin B, Wei Y, Yang Y, Cheng M, Jiang Y, Tian C, Zheng H, Fan Z, Jiang P, Gao Y, Wu J, Wang S, Sun B, Fang Z, Lei J, Luo B, Wen H, Peng G, Tang Y, Yang T, Chen J, Zhuang Z, Su X, Pan C, Zhu K, Shen Y, Liu S, Bao A, Yao J, Wang J, Xu X, Li XM, Liu L, Duan S, Zhang J. Wang P, et al. Among authors: luo t. Neuron. 2025 Jul 9;113(13):2123-2140.e9. doi: 10.1016/j.neuron.2025.03.002. Epub 2025 Mar 31. Neuron. 2025. PMID: 40168986
Consensus on clinical diagnosis and medical treatment of HER2-low breast cancer (2022 edition).
Hong B, Ying F, Zhaoqing F, Xichun H, Man L, Qiao L, Ning L, Ting L, Jianyun N, Yueyin P, Xiaowei Q, Zhimin S, Guohong S, Tao S, Yue-E T, Zhongsheng T, Jiayu W, Shusen W, Xue W, Yongsheng W, Zhonghua W, Binghe X, Ling X, Yan X, Wentao Y, Herui Y, Jianming Y, Peng Y, Jian Z, Qingyuan Z, Yongqiang Z, Jiuda Z. Hong B, et al. Among authors: ting l. J Natl Cancer Cent. 2023 Sep 29;3(4):266-272. doi: 10.1016/j.jncc.2023.09.002. eCollection 2023 Dec. J Natl Cancer Cent. 2023. PMID: 39036662 Free PMC article.
819 results